Cyclerion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Cyclerion Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Cyclerion Therapeutics Inc
Rating: 1.15966675
Author: Trendlyne DVM scores

about

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...

1.27 0.05 (4.10%)

New 52W Low in past week

35,295

XNAS Volume

XNAS 12 Feb, 2026 3:09 PM (EST)

Not Eligible

Expensive Valuation

29.2 / 100

Technically Bearish

17.2 / 100

1Yr Price target upside is 530%

1 analysts

Cyclerion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cyclerion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus i...

New 52W Low in past week

SWOT Analysis

Cyclerion Therapeutics Inc Live Price Chart